747-P: Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes TrialRichard E. Pratley, VLADO PERKOVIC, George L. Bakris et al.|Diabetes|2022Cited by 2